Trial Identifier: | D4194R00009 |
Sponsor: | AstraZeneca |
NCTID:: | NCT04023812 |
Start Date: | July 2019 |
Primary Completion Date: | February 2024 |
Study Completion Date: | February 2024 |
Condition: | Lung Cancer |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
China, China | Ji nan, China, China, 2501117 |
China, China | Ji nan, China, China, 2501117 |
China, China | Ji nan, China, China, 2501117 |
China, China | Ji nan, China, China, 2501117 |
China, China | Ji nan, China, China, 2501117 |
China, China | Ji nan, China, China, 2501117 |
China, China | Ji nan, China, China, 2501117 |
China, China | Ji nan, China, China, 2501117 |
China, China | Ji nan, China, China, 2501117 |
China, China | Ji nan, China, China, 2501117 |
China, China | Ji nan, China, China, 2501117 |
China, China | Ji nan, China, China, 2501117 |
China, China | Ji nan, China, China, 2501117 |
China, China | Ji nan, China, China, 2501117 |
China, China | Ji nan, China, China, 2501117 |
China, China | Ji nan, China, China, 2501117 |
China, China | Ji nan, China, China, 2501117 |
China, China | Ji nan, China, China, 2501117 |
China, China | Ji nan, China, China, 2501117 |
China, China | Ji nan, China, China, 2501117 |
China, China | Ji nan, China, China, 2501117 |
China, China | Ji nan, China, China, 2501117 |
China, China | Ji nan, China, China, 2501117 |
China, China | Ji nan, China, China, 2501117 |
China, China | Ji nan, China, China, 2501117 |